January 1, 2024 · Form 4 insider transaction
Balthaser Kevin bought 7,500 shares of Aclaris Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.